Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Influenza

  Free Subscription


18.02.2019

3 Antiviral Res
1 Arch Virol
1 Epidemiol Infect
1 J Gen Virol
2 J Immunol
1 J Infect Dis
1 J Virol
1 Lancet
3 MMWR Morb Mortal Wkly Rep
1 PLoS Genet
2 PLoS One
2 Proc Natl Acad Sci U S A
10 Vaccine
1 Virology


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Antiviral Res

  1. KOSZALKA P, Tilmanis D, Roe M, Vijaykrishna D, et al
    Baloxavir marboxil susceptibility of influenza viruses from the Asia-Pacific, 2012-2018.
    Antiviral Res. 2019 Feb 13. pii: S0166-3542(18)30698.
    PubMed     Text format     Abstract available

  2. MOHL G, Liddle N, Nygaard J, Dorius A, et al
    Novel influenza inhibitors designed to target PB1 interactions with host importin RanBP5.
    Antiviral Res. 2019 Feb 8. pii: S0166-3542(18)30487.
    PubMed     Text format     Abstract available

  3. HONG JY, Chen TH, Chen YJ, Liu CC, et al
    Highly immunogenic influenza virus-like particles containing B-cell-activating factor (BAFF) for multi-subtype vaccine development.
    Antiviral Res. 2019;164:12-22.
    PubMed     Text format     Abstract available


    Arch Virol

  4. NURPEISOVA A, Kassenov M, Rametov N, Tabynov K, et al
    Analysis of the efficacy of an adjuvant-based inactivated pandemic H5N1 influenza virus vaccine.
    Arch Virol. 2019 Feb 10. pii: 10.1007/s00705-019-04147.
    PubMed     Text format     Abstract available


    Epidemiol Infect

  5. DEMBEK ZF, Chekol T, Wu A
    Best practice assessment of disease modelling for infectious disease outbreaks.
    Epidemiol Infect. 2018;146:1207-1215.
    PubMed     Text format     Abstract available


    J Gen Virol

  6. VRIJENS P, Noppen S, Boogaerts T, Vanstreels E, et al
    Influenza virus entry via the GM3 ganglioside-mediated platelet-derived growth factor receptor beta signalling pathway.
    J Gen Virol. 2019 Feb 14. doi: 10.1099/jgv.0.001235.
    PubMed     Text format     Abstract available


    J Immunol

  7. VANGETI S, Gertow J, Yu M, Liu S, et al
    Human Blood and Tonsil Plasmacytoid Dendritic Cells Display Similar Gene Expression Profiles but Exhibit Differential Type I IFN Responses to Influenza A Virus Infection.
    J Immunol. 2019 Feb 13. pii: jimmunol.1801191. doi: 10.4049/jimmunol.1801191.
    PubMed     Text format     Abstract available

  8. FISCHER KJ, Yajjala VK, Bansal S, Bauer C, et al
    Monocytes Represent One Source of Bacterial Shielding from Antibiotics following Influenza Virus Infection.
    J Immunol. 2019 Feb 11. pii: jimmunol.1801471. doi: 10.4049/jimmunol.1801471.
    PubMed     Text format     Abstract available


    J Infect Dis

  9. LANGLEY JM
    Vaccine Prevention of Respiratory Syncytial Virus in Older Adults: The Work Continues.
    J Infect Dis. 2017 Sep 23. doi: 10.1093.
    PubMed     Text format    


    J Virol

  10. LIU G, Zhou Y
    Cytoplasm and Beyond: The Dynamic Innate Immune Sensing of Influenza A Virus by RIG-I.
    J Virol. 2019 Feb 13. pii: JVI.02299-18. doi: 10.1128/JVI.02299.
    PubMed     Text format     Abstract available


    Lancet

  11. SPINNEY L
    The Spanish flu: an interdisciplinary problem.
    Lancet. 2018;392:2552.
    PubMed     Text format    


    MMWR Morb Mortal Wkly Rep

  12. DOYLE JD, Chung JR, Kim SS, Gaglani M, et al
    Interim Estimates of 2018-19 Seasonal Influenza Vaccine Effectiveness - United States, February 2019.
    MMWR Morb Mortal Wkly Rep. 2019;68:135-139.
    PubMed     Text format     Abstract available

  13. HUGHES MM, Doyle JD, McCaffrey K, McMahon M, et al
    Notes from the Field: Assessment of State-Level Influenza Season Severity - Minnesota and Utah, 2017-18 Influenza Season.
    MMWR Morb Mortal Wkly Rep. 2019;68:165-166.
    PubMed     Text format    

  14. BLANTON L, Dugan VG, Abd Elal AI, Alabi N, et al
    Update: Influenza Activity - United States, September 30, 2018-February 2, 2019.
    MMWR Morb Mortal Wkly Rep. 2019;68:125-134.
    PubMed     Text format     Abstract available


    PLoS Genet

  15. LUMBY CK, Nene NR, Illingworth CJR
    A novel framework for inferring parameters of transmission from viral sequence data.
    PLoS Genet. 2018;14:e1007718.
    PubMed     Text format     Abstract available


    PLoS One

  16. VUICHARD-GYSIN D, Mertz D, Pullenayegum E, Singh P, et al
    Development and validation of clinical prediction models to distinguish influenza from other viruses causing acute respiratory infections in children and adults.
    PLoS One. 2019;14:e0212050.
    PubMed     Text format     Abstract available

  17. KURSKAYA O, Ryabichenko T, Leonova N, Shi W, et al
    Viral etiology of acute respiratory infections in hospitalized children in Novosibirsk City, Russia (2013 - 2017).
    PLoS One. 2018;13:e0200117.
    PubMed     Text format     Abstract available


    Proc Natl Acad Sci U S A

  18. VIBOUD C, Vespignani A
    The future of influenza forecasts.
    Proc Natl Acad Sci U S A. 2019 Feb 8. pii: 1822167116.
    PubMed     Text format    

  19. WHITE MC, Tao H, Steel J, Lowen AC, et al
    H5N8 and H7N9 packaging signals constrain HA reassortment with a seasonal H3N2 influenza A virus.
    Proc Natl Acad Sci U S A. 2019 Feb 13. pii: 1818494116.
    PubMed     Text format     Abstract available


    Vaccine

  20. DANCHIN MH, Costa-Pinto J, Attwell K, Willaby H, et al
    Vaccine decision-making begins in pregnancy: Correlation between vaccine concerns, intentions and maternal vaccination with subsequent childhood vaccine uptake.
    Vaccine. 2018;36:6473-6479.
    PubMed     Text format     Abstract available

  21. OHLROGGE AW, Suggs LS
    Flu vaccination communication in Europe: What does the government communicate and how?
    Vaccine. 2018 Apr 24. pii: S0264-410X(18)30525.
    PubMed     Text format     Abstract available

  22. BORGEY F, Henry L, Lebeltel J, Lescure P, et al
    Effectiveness of an intervention campaign on influenza vaccination of professionals in nursing homes: A cluster-randomized controlled trial.
    Vaccine. 2019 Feb 6. pii: S0264-410X(19)30151.
    PubMed     Text format     Abstract available

  23. PETRIE JG, Martin ET, Truscon R, Johnson E, et al
    Evaluation of correlates of protection against influenza A(H3N2) and A(H1N1)pdm09 infection: Applications to the hospitalized patient population.
    Vaccine. 2019 Feb 6. pii: S0264-410X(19)30131.
    PubMed     Text format     Abstract available

  24. HABER P, Moro PL, Ng C, Dores GM, et al
    Post-licensure surveillance of trivalent adjuvanted influenza vaccine (aIIV3; Fluad), Vaccine Adverse Event Reporting System (VAERS), United States, July 2016-June 2018.
    Vaccine. 2019 Feb 7. pii: S0264-410X(19)30128.
    PubMed     Text format     Abstract available

  25. YOUNG-XU Y, Snider JT, van Aalst R, Mahmud SM, et al
    Analysis of relative effectiveness of high-dose versus standard-dose influenza vaccines using an instrumental variable method.
    Vaccine. 2019 Feb 8. pii: S0264-410X(19)30148.
    PubMed     Text format     Abstract available

  26. PEPIN S, Samson SI, Alvarez FP, Dupuy M, et al
    Impact of a quadrivalent inactivated influenza vaccine on influenza-associated complications and health care use in children aged 6 to 35months: Analysis of data from a phase III trial in the Northern and Southern Hemispheres.
    Vaccine. 2019 Feb 8. pii: S0264-410X(19)30144.
    PubMed     Text format     Abstract available

  27. HERRERA-RODRIGUEZ J, Signorazzi A, Holtrop M, de Vries-Idema J, et al
    Inactivated or damaged? Comparing the effect of inactivation methods on influenza virions to optimize vaccine production.
    Vaccine. 2019 Feb 11. pii: S0264-410X(19)30184.
    PubMed     Text format     Abstract available

  28. ZENG Y, Yuan Z, Yin J, Han Y, et al
    Factors affecting parental intention to vaccinate kindergarten children against influenza: A cross-sectional survey in China.
    Vaccine. 2019 Feb 12. pii: S0264-410X(19)30156.
    PubMed     Text format     Abstract available

  29. CHAE W, Kim P, Hwang BJ, Seong BL, et al
    Universal monoclonal antibody-based influenza hemagglutinin quantitative enzyme-linked immunosorbent assay.
    Vaccine. 2019 Feb 11. pii: S0264-410X(19)30153.
    PubMed     Text format     Abstract available


    Virology

  30. KWON JH, Noh JY, Jeong JH, Jeong S, et al
    Different pathogenicity of two strains of clade 2.3.4.4c H5N6 highly pathogenic avian influenza viruses bearing different PA and NS gene in domestic ducks.
    Virology. 2019;530:11-18.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Influenza is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: